Vernalis Vernalis has reached a research milestone as part of the oncology drug discovery alliance with French pharmaceutical company, Servier
CytRx CytRx Initiates Phase 2 Clinical Trial with INNO-206 in Pancreatic Cancer
Cryolife CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Repligen Repligen hit by FDA setback, shares plummet 41 percent
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,